aap Implantate AG (AAQ):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:aap Implantate AG (AAQ) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6453
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
aap Implantate AG (aap Implantate) is a medical device company, which develops, manufactures and markets trauma products and biomaterials for orthopedic treatment. Its products include locked plating systems for anatomical reduction, cannulated screws, standard plates and screws for osteosynthesis, and orthopedic implants, besides trauma complementary biomaterials such as bone graft substitutes, and bone replacement materials. The pipeline of aap Implantate includes antibacterial silver coating technology and magnesium based implants for use in surgery. The company offers its products to hospitals, purchasing syndicates and hospital groups. Its products are used in the specialty areas of trauma and spine repair. The company markets its products directly and through a network of distributors worldwide. aap Implantate is headquartered in Berlin, Germany.

aap Implantate AG (AAQ) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
aap Implantate AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
aap Implantate AG, Medical Equipment Deals By Type, 2012 to YTD 2018 7
aap Implantate AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
aap Implantate AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
aap Implantate AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
aap Implantate AG, Medical Equipment, Deal Details 11
Private Equity 11
Keensight Capital Acquires aap Biomaterials from aap Implantate for USD41 Million 11
aap Implantate Sells European Medical Contract Manufacturing for USD25.7 Million 13
aap Implantate Sells 67% Stake in aap Joints to Private Equity Firm 14
Partnerships 15
aap Implantate Enters Into Licensing Agreement With Medical Technology Company For Injectable Bone Matrix 15
Integra LifeSciences Holdings Enters into Agreement with aap Implantate 16
aap Implantate Enters into Agreement with US Based Healthcare Service Provider 17
aap Implantate Forms Joint Venture With Dongguan Eontec To Develop Medical Implants 18
Integra LifeSciences Enters Into Distribution Agreement With aap Implantate For Stainless Headed Compression Screw System 19
aap Implantate Enters Into Licensing Agreement With Bioscompass For Adcon Gel 20
Acquisition 21
aap Implantate Sells Remaining 33% Stake in aap Joints 21
Botiss Medical Acquires Remaining 50% Joint Venture Interest in AAP BM Productions from aap Implantate 22
aap Implantate AG – Key Competitors 23
aap Implantate AG – Key Employees 24
aap Implantate AG – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Aug 14, 2018: aap Implantate: Double-digit Q2/2018 sales growth; sales and EBITDA at upper end of guidance 26
May 14, 2018: aap Implantate: Sound start to 2018 with sales and EBITDA at the upper end of the guidance 28
Aug 14, 2017: aap: Q2 sales and EBITDA in line with guidance; 14% sales growth in trauma in H1/2017aap: Q2 sales and EBITDA in line with guidance; 14% sales growth in trauma in H1/2017Berlin, 14 August 2017 29
Aug 14, 2017: aap Implantate: Q2 sales and EBITDA in line with guidance; 14% sales growth in trauma in H1/2017 31
May 15, 2017: aap Implantate: Successful start in 2017 with sales and EBITDA increase – 30% sales growth in trauma in Q1/2017 33
Apr 24, 2017: aap Implantate: 30% sales growth in trauma in the first quarter of 2017 35
Mar 31, 2017: aap: Annual financial statements for 2016: aap with fundamental progress in strategy implementation – Transformation to a pure player in trauma completed 36
Feb 28, 2017: aap: Sales in Q4/2016 at EUR 2.4 million and in FY/2016 at EUR 11.2 million; sales growth in established markets and EBITDA improvement planned for FY/2017 38
Corporate Communications 41
Jun 15, 2017: aap: Supervisory Board extends both Management Board members’ contracts prematurely until the end of 2020 41
Legal and Regulatory 42
Oct 01, 2017: OSARTIS – new logo of aap Biomaterials – new corporate design 42
Other Significant Developments 43
Feb 15, 2018: aap Implantate: 20% Trauma Sales Growth in 2017 43
Nov 14, 2017: aap Implantate: Double-digit trauma sales growth in Q3 and 9M/2017 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
aap Implantate AG, Medical Equipment, Key Facts, 2017 2
aap Implantate AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
aap Implantate AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
aap Implantate AG, Medical Equipment Deals By Type, 2012 to YTD 2018 7
aap Implantate AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
aap Implantate AG, Deals By Market, 2012 to YTD 2018 9
aap Implantate AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Keensight Capital Acquires aap Biomaterials from aap Implantate for USD41 Million 11
aap Implantate Sells European Medical Contract Manufacturing for USD25.7 Million 13
aap Implantate Sells 67% Stake in aap Joints to Private Equity Firm 14
aap Implantate Enters Into Licensing Agreement With Medical Technology Company For Injectable Bone Matrix 15
Integra LifeSciences Holdings Enters into Agreement with aap Implantate 16
aap Implantate Enters into Agreement with US Based Healthcare Service Provider 17
aap Implantate Forms Joint Venture With Dongguan Eontec To Develop Medical Implants 18
Integra LifeSciences Enters Into Distribution Agreement With aap Implantate For Stainless Headed Compression Screw System 19
aap Implantate Enters Into Licensing Agreement With Bioscompass For Adcon Gel 20
aap Implantate Sells Remaining 33% Stake in aap Joints 21
Botiss Medical Acquires Remaining 50% Joint Venture Interest in AAP BM Productions from aap Implantate 22
aap Implantate AG, Key Competitors 23
aap Implantate AG, Key Employees 24
aap Implantate AG, Subsidiaries 25

List of Figures
aap Implantate AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
aap Implantate AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
aap Implantate AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
aap Implantate AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
aap Implantate AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
aap Implantate AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
aap Implantate AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
aap Implantate AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[aap Implantate AG (AAQ):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Intellia Therapeutics Inc (NTLA):企業の財務・戦略的SWOT分析
    Summary Intellia Therapeutics Inc (Intellia Therapeutics) is a genome editing company that develops proprietary curative therapeutics using CRISPR/Cas9 technology. The company develops in vivo programs for the treatment of liver diseases such as alpha-1 antitrypsin deficiency, hepatitis B infection, …
  • Samyang Holdings Corp (000070):企業の財務・戦略的SWOT分析
    Summary Samyang Holdings Corp (Samyang) is a holding company engaged in the development and manufacture of food, pharmaceutical and chemical products. The company produces chemicals such as terephthalic acid, engineering plastics, organic chemicals, resins and other specialty chemicals; food materia …
  • Viasat Inc
    Viasat Inc - Strategy, SWOT and Corporate Finance Report Summary Viasat Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Vitabiotics Ltd:企業の戦略的SWOT分析
    Vitabiotics Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Nephros Inc (NEPH):企業の財務・戦略的SWOT分析
    Summary Nephros Inc (Nephros) is dialysis device manufacturer. The company offers infection control filters, dialysis ultrafilters, and hemodia filtration systems. Its dialysis ultrafilters includes Endotoxin ten Cartridge filter, SSUmini, DSU-D and SSU-D. Nephros dialysis ultrafilters are intended …
  • Ego Pharmaceuticals Pty Ltd:企業の戦略的SWOT分析
    Ego Pharmaceuticals Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Celonic AG-製薬・医療分野:企業M&A・提携分析
    Summary Celonic AG (Celonic), a subsidiary of JRS Pharma LP is a biotechnology company that provides contract development manufacturing organization services. The company’s services include development of cell lines and biotechnological production processes, full GMP analytics, and manufacture of ac …
  • Thor Industries, Inc.:企業の戦略・SWOT・財務情報
    Thor Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Thor Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sapience Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sapience Therapeutics Inc (Sapience) is a preclinical-stage biotechnology company that focuses on developing novel therapeutics for major unmet medical needs with special emphasis on high mortality cancers. The company offers peptides that act at the level of transcriptional regulation of on …
  • Eden Innovations (EDE):石油・ガス:M&Aディール及び事業提携情報
    Summary Eden Innovations, formerly Eden Energy Ltd, is a clean energy company that offers carbon nanotube and carbon fibre production, nanomaterial concrete admixtures, hydrogen production, and storage and transport fuel system. The company manufactures and distributes fuel systems, pumps, fuel tank …
  • Arkle Resources Plc
    Arkle Resources Plc - Strategy, SWOT and Corporate Finance Report Summary Arkle Resources Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Maybank Kim Eng Holdings Limited:企業の戦略・SWOT・財務情報
    Maybank Kim Eng Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Maybank Kim Eng Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Toyo Tanso Co Ltd (5310):企業の財務・戦略的SWOT分析
    Toyo Tanso Co Ltd (5310) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • SSP Group Ltd:企業の戦略・SWOT・財務分析
    SSP Group Ltd - Strategy, SWOT and Corporate Finance Report Summary SSP Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • AVANGRID, Inc.:企業の戦略・SWOT・財務分析
    AVANGRID, Inc. - Strategy, SWOT and Corporate Finance Report Summary AVANGRID, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • A.F. Blakemore & Son Ltd (Foodservice):企業の戦略・SWOT・財務情報
    A.F. Blakemore & Son Ltd (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary A.F. Blakemore & Son Ltd (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Venture Global LNG Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Venture Global LNG Inc (VGLI) is an exporter of american-produced liquefied natural gas. The company owns and manages two Louisiana-based export projects Calcasieu Pass and Plaquemines. The company through subsidiary Venture Global Calcasieu Pass, LLC, operates Calcasieu Pass project, which …
  • CHC Group Ltd:企業の戦略的SWOT分析
    CHC Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Pt Indofood Sukses Makmur Tbk
    Pt Indofood Sukses Makmur Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Indofood Sukses Makmur Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Aksigorta A.S. (AKGRT):企業の財務・戦略的SWOT分析
    Aksigorta A.S. (AKGRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆